Parkinsons & Movement Disorders
This session highlights breakthroughs in treating Parkinson’s disease, essential tremors, and complex dystonias. Topics include dopaminergic neuron preservation, deep brain stimulation surgical refinements, and early non-motor symptom tracking. Movement disorder specialists presenting at Stroke 2027 will discuss target identifying mechanisms, alpha-synuclein biomarkers, and individualized physical therapy. Participants will analyze the transition to advanced device-assisted therapies, learning how to build comprehensive care pathways that aggressively target motor fluctuations and preserve patient independence.